Profil Penggunaan Obat Antihipertensi di RSUD Mas Amsyar Kasongan Kabupaten Katingan A Profile of Antihypertensive Medicines in Mas Amsyar Hospital Kasongan Katingan Regency
Article Sidebar
-
Amlodipine, Descriptive, Hypertension, Mas Amsyar Hospital
Abstract
Hypertension or high blood pressure is one of the lead causes of death. Hypertension can cause various complications with another disease, even the cause of heart disease, stroke, and kidney disorders. Hypertension is the second rank of the most diseases in Kabupaten Katingan. The purpose of this research is to know the profile of antihypertensive medicines in RSUD Mas Amsyar Kasongan. Method of this research was a descriptive method with saturation sampling used retrospective data on all prescription drugs in 2017. The results of this research based on the patient characteristic were found 43.3% men and 56.7% women, meanwhile 45.8% age < 45 years old and 54.2% for age > 45 years old. The antihypertensive drug items used are propranolol, telmisartan, amlodipine, lisinopril, furosemide, ramipril, valsartan, candesartan, irbesartan, and bisoprolol, meanwhile based on the classification of antihypertensive drugs. are angiotensin II receptor blockers (ARB), diuretics, angiotensin converting enzyme Inhibitors (ACEI), Calcium Channel Blockers (CCB) and alpha 2 adrenergic agonists. Based on the result, it can be concluded that hypertension patient in RSUD Mas Amsyar Kasongan is mostly female (56.7%) and age of hypertension patient is > 45 years old (54.2%). The most antihypertensive prescribed is monotherapy (72%) and the most item of the drug is amlodipine. (38%).
Full text article
References
Gradman, A.H., Basile, J.N., Carter, B.L., Bakris, G.L. 2010. Combination Therapy in Hypertension, Journal of the American Society of Hypertension 4(2):90-98.
Kemenkes RI. 2012. Buletin dan Jendela Data dan Informasi Kesehatan: Penyakit Tidak Menular, bakti Husada hal: 29.
Kemenkes. 2014. Hipertensi. Infodatin Pusat Data dan Informasi Kementerian Kesehatan RI. Jakarta.
Natalia, D., Petrus Hasibuan, dan Hendro. 2014. Hubungan Obesitas dengan Hipertensi pada Penduduk Kecamatan Sintang, Kalimantan Barat. eJurnal Kedokteran Indonesia Vol 2 No. 3.
Novitaningtyas, T. 2014. Hubungan Karakterisrik (Umur, Jenis kelamin, Tingkat Pendidikan) dan Aktivitas Fisik dengan Tekanan Darah pada Lansia di Kelurahan Makamhaji Kecamatan Kartasura Kabupaten Sukoharjo. Naskah Publikasi. Program Studi Gizi Fakultas Ilmu Kesehatan Universitas Muhammadiyah Surakarta.
Tandililing, S., Mukaddas A dan Faustine I. 2016. Profil Penggunaan Obat Pasien Hipertensi Esensial di Instalasi Rawat Jalan Rumah Sakit Umum Daerah I Lagaligo Kabupaten Luwu Timur Periode Januari-Desember Tahun 2014. Journal of Pharmacy Vol. 3(1): 49-56.
Tjay, T.H dan Rahardja, K. 2007. Obat-obat Penting Khasiat, Penggunaan dan Efek-efek Sampingnya. Edisi Keenam PT. Elex Media Komputindo, Jakarta.
Tocci, G., Battistoni A., Passerini J., Musumeci M.B., Francia P., Ferruci A dan Volpe M. 2015. Calcium Channel Blockers and Hypertension. Journal of Cardiovascular Pharmacology and Therapeutics Vol 20 Issue 2.
Vera, Zukri Y. 2016. Evaluasi Penggunaan Antihipertensi terhadap Pengontrolan Tekanan Darah di Puskesmas Kraton dan Puskesmas Mergangsan Yogyakarta Tahun 2015. Skripsi. Program Studi Farmasi Fakultas Matematika dan Ilmu Pengetahuan Alam Universitas Islam Indonesia Yogyakarta.
Yosida, I. 2016. Efektifitas Penggunaan Obat Antihipertensi di Instalasi Rawat Inap Bangsal Bakung RSUD Panembahan Senopati Bantul Periode Agustus 2015. Skripsi. Fakultas Farmasi Universitas Sanata Dharma Yogyakarta.
Wahyuni dan Eksanoto, D. 2013. Hubungan Tingkat Pendidikan dan Jenis Kelamin dengan Kejadian Hipertensi di kelurahan Jagalan di Wilayah Kerja Puskesmas Pucang Sawit Surakarta. Jurnal Ilmu Keperawatan Indonesia. 1 (1):79-85.
Authors
Copyright (c) 2018 Syahrida Dian Ardhany, Wahyu Pandaran, Mohammad Rizki Fadhil Pratama
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors continue to retain the copyright to the article if the article is published in the Borneo Journal of Pharmacy. They will also retain the publishing rights to the article without any restrictions.
Authors who publish in this journal agree to the following terms:
- Any article on the copyright is retained by the author(s).
- The author grants the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share work with an acknowledgment of the work authors and initial publications in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of published articles (e.g., post-institutional repository) or publish them in a book, with acknowledgment of their initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their websites) prior to and during the submission process. This can lead to productive exchanges and earlier and greater citations of published work.
- The article and any associated published material are distributed under the Creative Commons Attribution-ShareAlike 4.0 International License.
Article Details
